High blood pressure medicine Rasilez gets approval in Japan
Thursday, July 09, 2009 13:00 IST Basel
Rasilez (aliskiren), the first new type of high blood pressure medicine in more than a decade, has been approved for use in Japan. Rasilez directly inhibits renin, an enzyme that triggers a process leading to high blood pressure and organ damage.
